Literature DB >> 19396495

AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference.

Jean-Nicolas Vauthey1, Elijah Dixon.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19396495     DOI： 10.1245/s10434-009-0409-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  39 in total

1.  AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.

Authors:  Elijah Dixon; Eddie Abdalla; Roderich E Schwarz; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 2.  The role of neoadjuvant therapy in pancreatic cancer: a review.

Authors:  Suzanne Russo; John Ammori; Jennifer Eads; Jennifer Dorth
Journal:  Future Oncol       Date:  2016-02-01       Impact factor: 3.404

3.  An Improved Staging System for Locally Advanced Pancreatic Cancer: A Critical Need in the Multidisciplinary Era.

Authors:  Marc W Fromer; Jenci Hawthorne; Prejesh Philips; Michael E Egger; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2021-06-04       Impact factor: 5.344

Review 4.  New challenges in perioperative management of pancreatic cancer.

Authors:  Francesco Puleo; Raphaël Maréchal; Pieter Demetter; Maria-Antonietta Bali; Annabelle Calomme; Jean Closset; Jean-Baptiste Bachet; Jacques Deviere; Jean-Luc Van Laethem
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

5.  AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases.

Authors:  Roderich E Schwarz; Eddie K Abdalla; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

6.  Preoperative therapies for resectable and borderline resectable pancreatic cancer.

Authors:  Gauri R Varadhachary
Journal:  J Gastrointest Oncol       Date:  2011-09

7.  DNA-SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma.

Authors:  Santanu Bhattacharya; Xun Gong; Enfeng Wang; Shamit K Dutta; Joseph R Caplette; Manki Son; Freddy T Nguyen; Michael S Strano; Debabrata Mukhopadhyay
Journal:  Cancer Res       Date:  2019-07-10       Impact factor: 12.701

8.  Neoadjuvant therapy for pancreatic cancer: an ongoing debate.

Authors:  Suzanne Russo; M Wasif Saif
Journal:  Therap Adv Gastroenterol       Date:  2016-05-10       Impact factor: 4.409

9.  Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.

Authors:  Brian K Bednarski; Mouhammed Amir Habra; Alexandria Phan; Denai R Milton; Christopher Wood; Nicholas Vauthey; Douglas B Evans; Matthew H Katz; Chaan S Ng; Nancy D Perrier; Jeffrey E Lee; Elizabeth G Grubbs
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

10.  Does Second Reader Opinion Affect Patient Management in Pancreatic Ductal Adenocarcinoma?

Authors:  Giuseppe Corrias; Sandra Huicochea Castellanos; Ryan Merkow; Russel Langan; Vinod Balachandran; Monica Ragucci; Gabriella Carollo; Marcello Mancini; Luca Saba; Lorenzo Mannelli
Journal:  Acad Radiol       Date:  2018-01-17       Impact factor: 3.173
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.